FLAG shareholders approve extension to Dec 14; 18.9M shares redeemed, co-CEO appointed

Calidi Biotherapeutics, Inc.

Stockholders approved extension of business combination deadline to Dec 14, 2022, with three additional 3-month extensions possible.
Redemption of 18,871,976 shares, leaving 4,128,024 shares outstanding; trust account now $41.6M.
Issued extension notes totaling $490,000 to sponsor and Metric to fund extension and working capital.
Appointed Thomas A. Vecchiolla as co-CEO alongside William J. Weber, effective Sept 15, 2022.

item 1.01 item 5.03 item 2.03 item 5.02 item 5.07 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Thomas A. Vecchiolla

co-Chief Executive Officer

CLDI · Calidi Biotherapeutics, Inc.

Effective: 2022-09-15
Filed: September 16, 2022, 7:59 PM ET

Effective September 15, 2022, the Company’s board of directors appointed Thomas A. Vecchiolla as co-Chief Executive Officer to serve in such role with William J. Weber, who will also serve as co-Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Thomas A. Vecchiolla was appointed as co-Chief Executive Officer at Calidi Biotherapeutics, Inc..

Action: appointed
Role: co-Chief Executive Officer

Exact text from the filing

Effective September 15, 2022, the Company’s board of directors appointed Thomas A. Vecchiolla as co-Chief Executive Officer to serve in such role with William J. Weber, who will also serve as co-Chief Executive Officer.

View on SEC.gov

Calidi Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-246494

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.